Analysis

The gene editing sector is witnessing remarkable developments as Intellia Therapeutics demonstrates groundbreaking progress with its CRISPR-based therapies. Within a...

Biopharmaceutical company Axsome Therapeutics has moved to resolve significant legal challenges through a proposed $7.75 million settlement agreement. This development...

The market is taking notice as Autodesk, a leader in design software, aggressively integrates artificial intelligence into its core offerings....

Keurig Dr Pepper is confronting one of its most significant investor confidence challenges in recent memory. As company leadership pursues...

Eli Lilly finds itself navigating contrasting fortunes as the pharmaceutical giant simultaneously celebrates a major regulatory victory while confronting an...

Morgan Stanley has designated Microsoft as its premier selection in the software sector, signaling strong confidence in the technology giant....

While numerous technology stocks face headwinds, U.S. telecommunications behemoth AT&T is doubling down on its established playbook: reliable dividend distributions...

The residential solar sector confronts mounting challenges as Sunnova Energy International Inc. finds itself navigating turbulent waters. The company's position...

As artificial intelligence continues to dominate technology discussions, Snowflake finds itself at the center of conversations about market valuations and...

Viking Therapeutics finds itself at a critical investment crossroads, pulled in opposite directions by two powerful market forces. Soaring takeover...